Drug Type Oligonucleotide |
Synonyms- |
Target |
Mechanism MIF inhibitors(Macrophage migration inhibitory factor inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Preclinical | US | 29 Nov 2024 | |
Rheumatoid Arthritis | Preclinical | US | 29 Nov 2024 |